Trexquant Investment LP lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 30.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,700 shares of the healthcare conglomerate’s stock after selling 5,100 shares during the period. Trexquant Investment LP’s holdings in UnitedHealth Group were worth $1,919,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of UNH. Patriot Financial Group Insurance Agency LLC increased its stake in shares of UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares during the period. Thomas J. Herzfeld Advisors Inc. bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $111,000. Cribstone Capital Management LLC increased its stake in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares during the last quarter. Israel Discount Bank of New York GFN acquired a new stake in UnitedHealth Group during the fourth quarter worth $139,000. Finally, Parkside Financial Bank & Trust increased its stake in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the last quarter. Hedge funds and other institutional investors own 86.37% of the company’s stock.
Shares of UnitedHealth Group Incorporated (UNH) traded down 1.16% during mid-day trading on Thursday, reaching $192.57. 2,647,121 shares of the company traded hands. UnitedHealth Group Incorporated has a 52 week low of $132.39 and a 52 week high of $196.04. The firm has a 50-day moving average price of $188.96 and a 200 day moving average price of $174.38. The firm has a market capitalization of $186.19 billion, a price-to-earnings ratio of 23.13 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter last year, the company earned $1.96 EPS. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. On average, analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “Trexquant Investment LP Has $1.92 Million Stake in UnitedHealth Group Incorporated (UNH)” was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://stocknewstimes.com/2017/08/10/trexquant-investment-lp-sells-5100-shares-of-unitedhealth-group-incorporated-unh-updated.html.
A number of equities research analysts have recently weighed in on UNH shares. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, June 28th. Deutsche Bank AG restated a “buy” rating and set a $187.00 price objective (up from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Sanford C. Bernstein restated an “outperform” rating and set a $190.00 price objective on shares of UnitedHealth Group in a research report on Monday, July 10th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $205.00 price objective (up previously from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Finally, Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday, May 19th. One equities research analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $200.24.
In other news, Director Gail R. Wilensky sold 5,540 shares of UnitedHealth Group stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the transaction, the director now owns 60,516 shares in the company, valued at approximately $10,816,629.84. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total value of $913,200.00. Following the transaction, the director now owns 75,735 shares in the company, valued at approximately $13,832,240.40. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,540 shares of company stock worth $2,873,320. 0.89% of the stock is currently owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
